In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma. (2022)
Attributed to:
Delivering Translational Opportunities From Edinburgh (DTOFE)
funded by
UKRI
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-21-2556
PubMed Identifier: 35074757
Publication URI: http://europepmc.org/abstract/MED/35074757
Type: Journal Article/Review
Volume: 82
Parent Publication: Cancer research
Issue: 8
ISSN: 0008-5472